An NMR-based metabolomics study reported low cholesterol levels in PKU patients, attributed to impaired cholesterol synthesis due to downregulated expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase [42]. This evidence concerns the gene HMGCR and phenylketonuria.